Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 27,883 | 25,591 | 28,603 | 20,573 | 19,818 |
| Operating Income | -27,883 | -25,591 | -28,603 | -20,573 | -19,818 |
| Other Income | -59 | -3 | 3 | -48 | -29 |
| Pre-tax Income | -27,942 | -25,594 | -28,600 | -20,621 | -19,847 |
| Income Tax | -14 | -127 | 47 | 9 | 68 |
| Net Income Continuous | -27,928 | -25,467 | -28,647 | -20,630 | -19,915 |
| Net Income | $-27,928 | $-25,467 | $-28,647 | $-20,630 | $-19,915 |
| EPS Basic Total Ops | -1.33 | -1.66 | -2.10 | -1.67 | -1.71 |
| EPS Basic Continuous Ops | -1.33 | -1.67 | -2.10 | -1.67 | -1.71 |
| EPS Diluted Total Ops | -1.33 | -1.66 | -2.10 | -1.67 | -1.71 |
| EPS Diluted Continuous Ops | -1.33 | -1.67 | -2.10 | -1.67 | -1.71 |
| EPS Diluted Before Non-Recurring Items | -1.33 | -1.67 | -2.10 | -1.67 | -1.71 |
| EBITDA(a) | $-27,791 | $-25,499 | $-28,513 | $-20,497 | $-19,771 |